Adamas Pharmaceuticals, Inc.

Q4 2017 13F Holders

Symbol
ADMS
CUSIP
00548A106
Type
Equity
Class
COM
Num filings
124
Total reported value, excl. options
$702 M
Manager Report Date Value ($000) Shares Option Type